查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1573180

导管直接溶栓市场设备：按产品类型、材料类型、设备设计、应用、治疗层级、患者年龄组和最终用户 - 2025-2030 年全球预测

Catheter-Directed Thrombolysis Devices Market by Product Type, Material Type (Nylon, Polyurethane, Polyvinyl Chloride ), Device Design, Application, Therapeutic Class, Patient Age Group, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年导管直接溶栓器械市值为4.3258亿美元，预计2024年将达到4.5745亿美元，复合年增长率为5.31%，到2030年将达到6亿美元，预计将达到2145万美元。

用于血栓治疗的导管直接溶栓（CDT）设备是溶栓治疗和介入心血管设备市场中令人兴奋的部分。其范围围绕着支持直接透过导管溶解血栓的微创手术，主要用于深层静脉栓塞症、肺动脉栓塞和周边血栓性栓塞症，门诊护理和专业诊所强调治疗的必要性。心血管疾病盛行率的增加、久坐的生活方式和人口老化是推动市场规模扩大的主要成长要素。技术进步，例如改进的导管设计以及与成像技术的集成，凸显了潜在的创新机会。公司应该专注于研究更有效的溶栓剂、更安全的程序，并可能使用人工智慧和机器学习来实现针对患者的治疗策略。

主要市场统计
基准年[2023] 43258万美元
预测年份 [2024] 45745万美元
预测年份 [2030] 6.2145亿美元
复合年增长率（%） 5.31%

主要成长领域包括拥有发达医疗基础设施以及与数位医疗平台整合以提高手术效率和结果的新兴市场。然而，高成本、严格的法规结构和潜在的程序併发症等挑战可能会阻碍市场成长。此外，机械血栓切除术和非侵入性治疗等替代方案的兴起可能会限制采用率。智慧财产权障碍以及与现有製药公司的竞争带来了额外的挑战。

为了利用这个机会，製造商应该投资研发，并专注于提高溶栓剂和生物相容性导管的安全性。为了解决这些限制，重点关注医疗保健专业人员的 CDT 技术教育和培训有可能提高利用率。与临床试验机构的伙伴关係和策略联盟可以提高已开发市场的可信度和接受度。因此，技术创新应优先考虑机器人技术和增强影像处理等跨领域技术的整合，以保持竞争优势并解决发展中地区的进入壁垒，同时满足监管要求。

市场动态：揭示快速发展的导管直接溶栓设备市场的关键市场洞察

供需的动态交互作用正在改变导管直接溶栓治疗设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 微创手术的扩展推动了对导管直接溶栓治疗设备的需求
    • 增加对研发活动的投资，以创新导管为基础的血栓溶解治疗方法
    • 增加医疗支出并专注于先进的患者照护解决方案
    • 医疗设备公司之间的联盟和伙伴关係，以扩大产品范围和效率
  • 市场限制因素
    • 导管溶栓设备核准的严格监管要求可能会延迟新产品的市场进入
    • 与直接导管溶栓相关的风险，例如出血和感染，可能会限制采用率
  • 市场机会
    • 先进影像技术的出现提高溶栓治疗的准确性和有效性
    • 创新导致下一代导管直接溶栓系统的开发
    • 将人工智慧和机器学习整合到手术规划和治疗结果预测中
  • 市场挑战
    • 导管直接溶栓治疗装置最佳操作所需的技术复杂性与专业知识
    • 溶栓治疗市场中其他微创疗法和药物疗法的竞争

波特五力：驾驭导管直接溶栓设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解导管直接溶栓设备市场的外部影响

外部宏观环境因素在塑造导管直接溶栓设备市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解导管直接溶栓设备市场的竞争格局

对导管直接溶栓设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵导管直接溶栓设备市场供应商的绩效评估

FPNV定位矩阵是评估导管直接溶栓设备市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了导管直接溶栓设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对导管直接溶栓设备市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 微创手术的扩展推动了对导管直接溶栓治疗设备的需求
      • 增加对研发活动的投资，以创新导管为基础的血栓溶解治疗方法
      • 医疗保健成本上升并专注于先进的患者照护解决方案
      • 医疗设备公司之间的协作和伙伴关係，以提高产品采用率和效率
    • 抑制因素
      • 导管溶栓设备核准的严格监管要求可能会延迟新产品的市场进入
      • 与导管导引溶栓相关的风险，例如出血和感染，可能会限制实施率。
    • 机会
      • 引进先进影像技术，提升溶栓治疗的准确性与有效性
      • 技术创新促进下一代导管引导溶栓系统的开发
      • 将人工智慧和机器学习整合到程式规划和结果预测中
    • 任务
      • 优化操作基于导管的溶栓装置所需的技术复杂性和专业知识。
      • 溶栓治疗市场中替代微创疗法和药物疗法的竞争
  • 市场区隔分析
  • 波特五力分析
  • PESTLE分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章导管直接溶栓设备市场：依产品类型

  • 附属装置
    • 导管导引器
    • 导管导引线
    • 点滴帮浦
  • 溶栓输液导管
    • 微注射导管
    • 标准溶栓输注导管

第 7 章依材料类型分類的导管直接溶栓设备市场

  • 尼龙
  • 聚氨酯
  • 聚氯乙烯（PVC）
  • 硅胶

第八章导管直接溶栓装置市场装置设计

  • 双腔
  • 多重腔
  • 单腔

第九章导管直接溶栓设备市场：依应用分类

  • 急性肢体缺血
  • 深层静脉栓塞症
  • 肺动脉栓塞

第10章依治疗层级分類的导管直接溶栓设备市场

  • 抗凝血物
  • 溶栓剂

第十一章依病患年龄组别分類的导管直接溶栓装置市场

  • 成人
  • 老年医学
  • 小儿科

第十二章导管直接溶栓设备市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第13章：美洲导管直接溶栓设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十四章亚太导管直接溶栓器械市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第15章：欧洲、中东和非洲的导管直接溶栓装置市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议
Product Code: MRR-1A1A064C03AA

The Catheter-Directed Thrombolysis Devices Market was valued at USD 432.58 million in 2023, expected to reach USD 457.45 million in 2024, and is projected to grow at a CAGR of 5.31%, to USD 621.45 million by 2030.

Catheter-Directed Thrombolysis (CDT) devices, used in the medical treatment of blood clots, represent a focused segment within the larger thrombolytic therapy and interventional cardiovascular device markets. The scope revolves around aiding minimally invasive procedures to dissolve clots directly through a catheter, emphasizing their necessity in treating deep vein thrombosis, pulmonary embolism, and peripheral arterial thromboembolism, primarily in hospital settings, ambulatory care, and specialized clinics. The increasing prevalence of cardiovascular diseases, sedentary lifestyles, and aging populations are key growth drivers, promoting a larger market size. Technological advancements, such as improved catheter designs and integration with imaging technologies, highlight potential opportunities for innovation. Companies should focus on research into more efficient thrombolytic agents and safer procedure techniques, potentially using AI and machine learning for patient-specific treatment strategies.

KEY MARKET STATISTICS
Base Year [2023] USD 432.58 million
Estimated Year [2024] USD 457.45 million
Forecast Year [2030] USD 621.45 million
CAGR (%) 5.31%

Key growth areas include emerging markets with healthcare infrastructure development, while collaboration with digital health platforms can improve procedural efficiency and outcomes. However, challenges such as high costs, stringent regulatory frameworks, and potential procedural complications could hinder market growth. Moreover, rising alternatives like mechanical thrombectomy and non-invasive treatments might limit the adoption rate. Intellectual property hurdles and competition from established pharmaceutical companies pose additional challenges.

To leverage opportunities, manufacturers should invest in R&D focused on enhancing safety profiles of thrombolytic agents and bio-compatible catheters. Addressing limitations, emphasis on education and training for healthcare professionals regarding CDT techniques can potentially boost usage rates. Partnerships and strategic alliances with institutions for clinical trials can foster credibility and acceptance in developed markets. Thus, innovation should prioritize integrating cross-disciplinary technologies such as robotics and enhanced imaging to maintain competitive advantage while meeting regulatory requirements and addressing the barriers to entry in developing regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Catheter-Directed Thrombolysis Devices Market

The Catheter-Directed Thrombolysis Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Expansion of minimally invasive procedures driving the demand for catheter-directed thrombolysis devices
    • Growing investment in research and development activities to innovate catheter-based thrombolysis treatment methods
    • Increasing healthcare expenditure and focus on advanced patient care solutions
    • Collaborations and partnerships among medical device companies to enhance product reach and efficiency
  • Market Restraints
    • Strict regulatory requirements for approval of catheter-directed thrombolysis devices may delay market entry for new products
    • Risks associated with catheter-directed thrombolysis procedures, such as bleeding and infection, may limit adoption rates
  • Market Opportunities
    • Emergence of advanced imaging technologies improving precision and efficacy of thrombolysis procedures
    • Technological innovations leading to development of next-generation catheter-directed thrombolysis systems
    • Integration of artificial intelligence and machine learning in procedure planning and outcome prediction
  • Market Challenges
    • Technical complexities and expertise required for optimal operation of catheter-directed thrombolysis devices
    • Competition from alternative minimally invasive and pharmacological therapies in the thrombolysis market

Porter's Five Forces: A Strategic Tool for Navigating the Catheter-Directed Thrombolysis Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Catheter-Directed Thrombolysis Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Catheter-Directed Thrombolysis Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Catheter-Directed Thrombolysis Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Catheter-Directed Thrombolysis Devices Market

A detailed market share analysis in the Catheter-Directed Thrombolysis Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Catheter-Directed Thrombolysis Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Catheter-Directed Thrombolysis Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Catheter-Directed Thrombolysis Devices Market

A strategic analysis of the Catheter-Directed Thrombolysis Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Catheter-Directed Thrombolysis Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AngioDynamics, Inc., Asahi Intecc Co., Ltd., Bayer AG, Boston Scientific Corporation, BTG International Ltd., Cardinal Health, Inc., Cook Medical Inc., Cordis Corporation, Endocor GmbH, iVascular S.L.U., Koninklijke Philips N.V., Medline Industries, Inc., Medtronic plc, Merit Medical Systems, Inc., MicroVention, Inc., Penumbra Inc., Stryker Corporation, Teleflex Incorporated, and Terumo Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Catheter-Directed Thrombolysis Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Accessory Devices and Thrombolytic Infusion Catheters. The Accessory Devices is further studied across Catheter Introducers, Guidewires, and Infusion Pumps. The Thrombolytic Infusion Catheters is further studied across Micro Infusion Catheters and Standard Thrombolytic Infusion Catheters.
  • Based on Material Type, market is studied across Nylon, Polyurethane, Polyvinyl Chloride (PVC), and Silicone.
  • Based on Device Design, market is studied across Dual Lumen, Multi-Lumen, and Single Lumen.
  • Based on Application, market is studied across Acute Limb Ischemia, Deep Vein Thrombosis, and Pulmonary Embolism.
  • Based on Therapeutic Class, market is studied across Anticoagulants and Thrombolytics.
  • Based on Patient Age Group, market is studied across Adults, Geriatrics, and Pediatrics.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of minimally invasive procedures driving the demand for catheter-directed thrombolysis devices
      • 5.1.1.2. Growing investment in research and development activities to innovate catheter-based thrombolysis treatment methods
      • 5.1.1.3. Increasing healthcare expenditure and focus on advanced patient care solutions
      • 5.1.1.4. Collaborations and partnerships among medical device companies to enhance product reach and efficiency
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulatory requirements for approval of catheter-directed thrombolysis devices may delay market entry for new products
      • 5.1.2.2. Risks associated with catheter-directed thrombolysis procedures, such as bleeding and infection, may limit adoption rates
    • 5.1.3. Opportunities
      • 5.1.3.1. Emergence of advanced imaging technologies improving precision and efficacy of thrombolysis procedures
      • 5.1.3.2. Technological innovations leading to development of next-generation catheter-directed thrombolysis systems
      • 5.1.3.3. Integration of artificial intelligence and machine learning in procedure planning and outcome prediction
    • 5.1.4. Challenges
      • 5.1.4.1. Technical complexities and expertise required for optimal operation of catheter-directed thrombolysis devices
      • 5.1.4.2. Competition from alternative minimally invasive and pharmacological therapies in the thrombolysis market
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Catheter-Directed Thrombolysis Devices Market, by Product Type

  • 6.1. Introduction
  • 6.2. Accessory Devices
    • 6.2.1. Catheter Introducers
    • 6.2.2. Guidewires
    • 6.2.3. Infusion Pumps
  • 6.3. Thrombolytic Infusion Catheters
    • 6.3.1. Micro Infusion Catheters
    • 6.3.2. Standard Thrombolytic Infusion Catheters

7. Catheter-Directed Thrombolysis Devices Market, by Material Type

  • 7.1. Introduction
  • 7.2. Nylon
  • 7.3. Polyurethane
  • 7.4. Polyvinyl Chloride (PVC)
  • 7.5. Silicone

8. Catheter-Directed Thrombolysis Devices Market, by Device Design

  • 8.1. Introduction
  • 8.2. Dual Lumen
  • 8.3. Multi-Lumen
  • 8.4. Single Lumen

9. Catheter-Directed Thrombolysis Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Acute Limb Ischemia
  • 9.3. Deep Vein Thrombosis
  • 9.4. Pulmonary Embolism

10. Catheter-Directed Thrombolysis Devices Market, by Therapeutic Class

  • 10.1. Introduction
  • 10.2. Anticoagulants
  • 10.3. Thrombolytics

11. Catheter-Directed Thrombolysis Devices Market, by Patient Age Group

  • 11.1. Introduction
  • 11.2. Adults
  • 11.3. Geriatrics
  • 11.4. Pediatrics

12. Catheter-Directed Thrombolysis Devices Market, by End User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Hospitals
  • 12.4. Specialty Clinics

13. Americas Catheter-Directed Thrombolysis Devices Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Catheter-Directed Thrombolysis Devices Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Catheter-Directed Thrombolysis Devices Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2023
  • 16.2. FPNV Positioning Matrix, 2023
  • 16.3. Competitive Scenario Analysis
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AngioDynamics, Inc.
  • 3. Asahi Intecc Co., Ltd.
  • 4. Bayer AG
  • 5. Boston Scientific Corporation
  • 6. BTG International Ltd.
  • 7. Cardinal Health, Inc.
  • 8. Cook Medical Inc.
  • 9. Cordis Corporation
  • 10. Endocor GmbH
  • 11. iVascular S.L.U.
  • 12. Koninklijke Philips N.V.
  • 13. Medline Industries, Inc.
  • 14. Medtronic plc
  • 15. Merit Medical Systems, Inc.
  • 16. MicroVention, Inc.
  • 17. Penumbra Inc.
  • 18. Stryker Corporation
  • 19. Teleflex Incorporated
  • 20. Terumo Medical Corporation

LIST OF FIGURES

  • FIGURE 1. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 19. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 23. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 28. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 29. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY CATHETER INTRODUCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MICRO INFUSION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STANDARD THROMBOLYTIC INFUSION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY NYLON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY POLYVINYL CHLORIDE (PVC), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY SILICONE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DUAL LUMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MULTI-LUMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACUTE LIMB ISCHEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ANTICOAGULANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 53. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 68. BRAZIL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 76. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 77. CANADA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 83. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 85. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. MEXICO CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 90. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 92. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED STATES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 109. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 110. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 112. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 118. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 119. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 121. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 124. CHINA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 128. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 130. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 133. INDIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 137. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 139. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. INDONESIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 145. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 146. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 148. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 150. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 151. JAPAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 154. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 155. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 157. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 159. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 160. MALAYSIA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 164. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 166. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 168. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 169. PHILIPPINES CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 173. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 175. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 177. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 178. SINGAPORE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 182. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 184. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 186. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. SOUTH KOREA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 191. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 193. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 195. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 196. TAIWAN CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 199. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 200. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 202. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 204. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 205. THAILAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 209. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 211. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 213. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 214. VIETNAM CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 225. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 228. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 230. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 232. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 233. DENMARK CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 234. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 236. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 237. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 239. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 241. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 242. EGYPT CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 243. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 245. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 246. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 248. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 250. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 251. FINLAND CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 254. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 255. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 257. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 258. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 259. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 260. FRANCE CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 262. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 263. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 264. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 266. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 267. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 268. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 269. GERMANY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 270. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 271. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 272. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 273. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY DEVICE DESIGN, 2018-2030 (USD MILLION)
  • TABLE 275. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 276. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
  • TABLE 277. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 278. ISRAEL CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. ITALY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 280. ITALY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY ACCESSORY DEVICES, 2018-2030 (USD MILLION)
  • TABLE 281. ITALY CATHETER-DIRECTED THROMBOLYSIS DEVICES MARKET SIZE, BY THROMBOLYTIC INFUSION CATHETERS, 2018-2030 (USD MILLION)
  • TABLE 282. ITALY CATHET